» Articles » PMID: 17372989

Btk and Phospholipase C Gamma 2 Can Function Independently During B Cell Development

Overview
Journal Eur J Immunol
Date 2007 Mar 21
PMID 17372989
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The pre-BCR and the BCR regulate B cell development via a signalosome nucleated by the adaptor protein B cell linker protein (BLNK). Formation of this complex facilitates activation of phospholipase C (PLC) gamma2 by Bruton's tyrosine kinase (Btk). To determine whether Btk and PLCgamma2 also have separate functions, we generated Btk(-/-)PLCgamma2(-/-) mice. They demonstrated a block in development at the pre-B stage and increased pre-BCR surface expression. This phenotype was more severe than that of Btk(-/-) or PLCgamma2(-/-) mice. Although both Btk and PLCgamma2 were required for proliferation of splenic B cells in response to BCR cross-linking, they contributed differently to anti-IgM-induced phosphorylation of ERK. Btk(-/-) and PLCgamma2(-/-) mice each had a reduced frequency of Iglambda-expressing B cells and impaired migration of pre-B cells towards stromal cell-derived factor 1. However, the increase in pre-B cell malignancy that occurs in BLNK(-/-) mice in the absence of Btk was not observed in the absence of PLCgamma2. Thus, Btk and PLCgamma2 act both in concert and independently throughout B cell development.

Citing Articles

Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors.

Sousa B, de Almeida C, Barahona A, Lopes R, Martins-Logrado A, Cavaco M ACS Pharmacol Transl Sci. 2022; 5(11):1156-1168.

PMID: 36407952 PMC: 9667546. DOI: 10.1021/acsptsci.2c00163.


Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.

Kifle Z Metabol Open. 2021; 11:100116.

PMID: 34345815 PMC: 8318668. DOI: 10.1016/j.metop.2021.100116.


Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.

Good L, Benner B, Carson W Cancer Immunol Immunother. 2021; 70(9):2439-2451.

PMID: 33818636 PMC: 8019691. DOI: 10.1007/s00262-021-02908-5.


Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation.

Kim J, Park J, Noh E, Song H, Kang S, Jung S Oncol Rep. 2021; 45(5).

PMID: 33760219 PMC: 7962096. DOI: 10.3892/or.2021.8007.


Increased sensitivity of BCR-ABL-induced B-ALL to imatinib by releasing leukemia B cell differentiation blockage.

Wang Z, Li Y, Lu X, Yuan J, Qiu Q, Pan C Int J Clin Exp Pathol. 2020; 13(11):2738-2745.

PMID: 33284894 PMC: 7716132.